| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $24K | +1817.6% | +4313.4% |
| Cost of Revenue | $26K | +649.8% | +1625.3% |
| Gross Profit | -$2K | +26.5% | -69.2% |
| R&D Expense | $1.8M | -5.6% | +6.5% |
| SG&A Expense | $959K | +6.9% | +7.3% |
| Operating Income | -$3.0M | +3.8% | -4.2% |
| Net Income | -$2.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.4M | -24.4% | -55.0% |
| Accounts Receivable | $32K | +285.3% | +2275.6% |
| Inventory | $65K | -15.9% | +8.2% |
| Current Assets | $8.7M | -24.1% | -54.4% |
| Total Assets | $12.2M | -18.2% | -45.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.0M | — | — |
| Capital Expenditures | $111K | — | — |
| Investing Cash Flow | -$377K | — | — |
| Financing Cash Flow | -$99K | — | — |
| Free Cash Flow | -$7.1M | — | — |
| +3.2% |
| -9.3% |
| EPS (Basic) | -$0.32 | +3.0% | -3.2% |
| $889K |
| -1.7% |
| -2.0% |
| Total Liabilities | $2.2M | -2.6% | -9.6% |
| Stockholders' Equity | $10.1M | -20.9% | -50.2% |